486 related articles for article (PubMed ID: 34087152)
21. Post-vaccination SARS-CoV-2 axillary adenopathy. Differences with axillary metastases from breast cancer.
Armas-Conde M; Sánchez-Álvarez ÁL; Tejera-Hernández A; Vega-Benítez V; Antela-López JC; Gutiérrez-Giner MI; Hernández-Hernández JR
Cir Cir; 2022; 90(3):410-413. PubMed ID: 35636962
[TBL] [Abstract][Full Text] [Related]
22. [SARS-CoV-2 vaccines - what the nephrologist should know].
Heine GH; Becker SL; Scheuer AL; Schirmer SH
Dtsch Med Wochenschr; 2021 Apr; 146(7):466-470. PubMed ID: 33780993
[TBL] [Abstract][Full Text] [Related]
23. Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination: A New Diagnostic Dilemma.
Ashoor A; Shephard J; Lissidini G; Nicosia L
Korean J Radiol; 2022 Jul; 23(7):775-776. PubMed ID: 35695318
[No Abstract] [Full Text] [Related]
24. Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results.
Lombardi A; Bozzi G; Ungaro R; Villa S; Castelli V; Mangioni D; Muscatello A; Gori A; Bandera A
Front Immunol; 2021; 12():657711. PubMed ID: 33777055
[No Abstract] [Full Text] [Related]
25. FDG-Avid Ipsilateral Iliac and Inguinal Lymphadenopathy After COVID-19 Vaccination With Thigh Injection.
Bass D; Puri S
AJR Am J Roentgenol; 2022 Jan; 218(1):180. PubMed ID: 34259040
[No Abstract] [Full Text] [Related]
26. Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of COVID-19 Vaccination.
Edmonds CE; Zuckerman SP; Conant EF
AJR Am J Roentgenol; 2021 Oct; 217(4):831-834. PubMed ID: 33543649
[TBL] [Abstract][Full Text] [Related]
27. COVID-19 vaccines for patients with haematological conditions.
Sun C; Pleyer C; Wiestner A
Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822
[No Abstract] [Full Text] [Related]
28. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH.
Oldenburg J; Klamroth R; Langer F; Albisetti M; von Auer C; Ay C; Korte W; Scharf RE; Pötzsch B; Greinacher A
Hamostaseologie; 2021 Jun; 41(3):184-189. PubMed ID: 33822348
[TBL] [Abstract][Full Text] [Related]
29. Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021.
Fernández-Prada M; Rivero-Calle I; Calvache-González A; Martinón-Torres F
Euro Surveill; 2021 Mar; 26(10):. PubMed ID: 33706861
[TBL] [Abstract][Full Text] [Related]
30. Reply to comment to "axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: a single-centre experience in 285 women".
Marcon M; Catanese C; Scarano AL; Del Grande F; Manganiello M; Palermo M; Rizzo S
Radiol Med; 2023 Dec; 128(12):1595-1596. PubMed ID: 37907674
[No Abstract] [Full Text] [Related]
31. Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.
Pascolo S
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572452
[TBL] [Abstract][Full Text] [Related]
32. Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine.
Holzworth A; Couchot P; Cruz-Knight W; Brucculeri M
Kidney Int; 2021 Aug; 100(2):463-464. PubMed ID: 34048824
[No Abstract] [Full Text] [Related]
33. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine.
Zeng G
Lancet Microbe; 2022 Aug; 3(8):e561. PubMed ID: 35659883
[No Abstract] [Full Text] [Related]
34. Minimal change disease relapse following SARS-CoV-2 mRNA vaccine.
Kervella D; Jacquemont L; Chapelet-Debout A; Deltombe C; Ville S
Kidney Int; 2021 Aug; 100(2):457-458. PubMed ID: 33964312
[No Abstract] [Full Text] [Related]
35. Radiation recall dermatitis triggered by inactivated COVID-19 vaccine.
Afacan E; Öğüt B; Üstün P; Şentürk E; Yazıcı O; Adışen E
Clin Exp Dermatol; 2021 Dec; 46(8):1582-1584. PubMed ID: 34080223
[No Abstract] [Full Text] [Related]
36. How COVID unlocked the power of RNA vaccines.
Dolgin E
Nature; 2021 Jan; 589(7841):189-191. PubMed ID: 33437061
[No Abstract] [Full Text] [Related]
37. Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations.
Ohsawa R; Sano H; Ikeda M; Sano S
J Dermatol Sci; 2021 Aug; 103(2):124-127. PubMed ID: 34167874
[No Abstract] [Full Text] [Related]
38.
Steinberg J; Thomas A; Iravani A
Lancet; 2021 Mar; 397(10279):e9. PubMed ID: 33705696
[No Abstract] [Full Text] [Related]
39. COVID-19 vaccination-associated ipsilateral supraclavicular lymphadenopathy.
Jalani N; Tadj D
Aust J Gen Pract; 2021 Dec; 50():. PubMed ID: 35398876
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
Peter J
S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
